Aug 2026· Investigative Ophthalmology and Visual Science· Vol 67· 0 citations· 38 references
Medicine
TL;DR
A novel mechanistic link is revealed among WDR34, retrograde IFT, ciliopathies, and retinal degeneration, providing potential therapeutic insights for ciliopathy-associated RP and its contribution to retinal degeneration.
Abstract
Purpose Retinitis pigmentosa (RP) is a hereditary retinal disease characterized by progressive photoreceptor cell (PRC) degeneration. WD repeat domain 34 (WDR34), an intermediate chain of dynein-2, is essential for retrograde intraflagellar transport (IFT). However, the mechanisms by which WDR34 deficiency causes retinal degeneration remain unclear. This study aims to investigate the impact of WDR34 deficiency on retrograde IFT and its contribution to retinal degeneration. Methods WDR34 deficiency was modeled in vivo via subretinal injection of adeno-associated virus–shRNA–WDR34 and in vitro by CRISPR/Cas9-mediated knockout in 661W cells. Retinal degeneration and IFT defects were assessed by histologic, functional, and ultrastructural analyses. Proteomic analysis followed by in vivo validation was used to investigate the molecular mechanism underlying WDR34-deficient retinal degeneration. Results WDR34 knockdown induced progressive retinal degeneration characterized by PRC apoptosis, gradual outer nuclear layer thinning, reduced electroretinography responses, and outer segment shortening. WDR34 deficiency impaired retrograde IFT and caused rhodopsin and opsin mislocalization. These alterations induced endoplasmic reticulum stress and unfolded protein response (UPR) activation, activating the IRE1α/TRAF2/NF-κB signaling pathway, ultimately contributing to retinal inflammation and degeneration. Conclusions WDR34 is crucial for maintaining retrograde IFT in PRCs. WDR34 deficiency disrupts outer segment maintenance and triggers UPR-mediated inflammatory responses and apoptosis, ultimately leading to retinal degeneration. This study reveals a novel mechanistic link among WDR34, retrograde IFT, ciliopathies, and retinal degeneration, providing potential therapeutic insights for ciliopathy-associated RP.
It is found that restoring CRB1-B to photoreceptors prevents degeneration and completely rescues visual function, despite the absence of other isoforms, and suggests that exploring disease gene isoform diversity offers an untapped opportunity to devise novel therapeutics.
Ekta Dembla, Juan C. Valdez-Lopez, Christopher Kozlowski et al.· bioRxiv· 0 citations
Despite the expression of many cargo adaptor proteins and dynein activators in the retina, a novel non-redundant role of Bicdl1 in retinal homeostasis is identified.
Gizem Ulker-Yilmazer, Dogan Can Kirman, Tian Yu et al.· Molecular Vision· 0 citations
It is indicated that PRPH2-associated retinal dystrophy is a multicellular process in which OS disruption drives coordinated RPE and Müller glial remodeling with potentially protective or pro-degenerative effects, and nominate the RPE Nfib-Fstl1 program, Müller glial AP-1 responses with predicted STAT3 involvement, and...
Haoxin Guo, Linfei Wei, Binghan Chen et al.· Neurobiology of Disease· 0 citations
ADORA2A activation promotes Rubicon-associated, lysosome-dependent LC3 processing of internalized POS and restores lysosomal degradative competence, supporting ADORA2A as a potential therapeutic target for early AMD.
D. Tao, Daiyi Zhou, Ming-Juan Wu et al.· Frontiers in Physiology· 0 citations
Results identify Cryaa as a critical regulator of ER stress and demonstrate that its reduction promotes UPR activation and subsequent photoreceptor apoptosis in the rd9 model, revealing a key role for Cryaa in XLRP pathology and may provide a novel therapeutic perspective for this disease.
Ming-Zhu Yang, Rui-Qi Qiu, S. Yao et al.· Cell Death & Disease· 0 citations
Results from this work demonstrate that ageing and sex influence retinal degeneration, and identify inflammatory biomarkers accompanied by visual function loss, prior to evident retinal degeneration, and demonstrate that age and sex critically shape disease onset and severity.
Enola Missonnier, Lorena Vidal-Gil, Carla Sánchez-Castillo et al.· Cell Death Discovery· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.